학술논문
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
Document Type
Article
Author
Source
In Clinical Colorectal Cancer September 2021 20(3):227-235
Subject
Language
ISSN
1533-0028